AR093270A1 - METODO DE PREPARACION DE COMPUESTOS DE a-GALACTOSILCERAMIDAS - Google Patents
METODO DE PREPARACION DE COMPUESTOS DE a-GALACTOSILCERAMIDASInfo
- Publication number
- AR093270A1 AR093270A1 ARP130103950A ARP130103950A AR093270A1 AR 093270 A1 AR093270 A1 AR 093270A1 AR P130103950 A ARP130103950 A AR P130103950A AR P130103950 A ARP130103950 A AR P130103950A AR 093270 A1 AR093270 A1 AR 093270A1
- Authority
- AR
- Argentina
- Prior art keywords
- group
- compound
- formula
- optionally substituted
- alkyl
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 2
- 125000006239 protecting group Chemical group 0.000 abstract 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 3
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 2
- 125000000592 heterocycloalkyl group Chemical group 0.000 abstract 2
- 229920006395 saturated elastomer Polymers 0.000 abstract 2
- 125000003837 (C1-C20) alkyl group Chemical group 0.000 abstract 1
- 125000000923 (C1-C30) alkyl group Chemical group 0.000 abstract 1
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 abstract 1
- 239000002841 Lewis acid Substances 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 230000013595 glycosylation Effects 0.000 abstract 1
- 238000006206 glycosylation reaction Methods 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 150000007517 lewis acids Chemical class 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/28—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/12—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
- C07H15/06—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical being a hydroxyalkyl group esterified by a fatty acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/18—Acyclic radicals, substituted by carbocyclic rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Reivindicación 1: Método de preparación de un compuesto de fórmula (1) caracterizado porque comprende una etapa a) de glicosilación, preferentemente, en presencia de un ácido de Lewis, de un compuesto de fórmula (2) con un compuesto de fórmula (3) dicha etapa a) brinda un compuesto de fórmula (4) en la cual: R¹ representa un grupo alquilo C₁₋₂₀, lineal o ramificado, saturado o no saturado, opcionalmente sustituido; R² representa un grupo alquilo C₁₋₃₀, lineal o ramificado, saturado o no saturado, opcionalmente sustituido; R³ representa alquilo C₁₋₆, un cicloalquilo C₃₋₆, un acilo C₁₋₆ o un grupo benzoilo; y R⁴ representa H o un grupo alquilo C₁₋₆; o R³ y R⁴ forman junto con el átomo de nitrógeno al cual están unidos un grupo heterocicloalquilo C₂₋₆ o un grupo heteroarilo C₁₋₅; PG¹ representa un grupo protector de función hidroxilo; PG² representa un grupo protector de función amina primaria; PG³ representa un grupo protector de función hidroxilo; PG³ representa un grupo protector de función hidroxilo, que forma opcionalmente, junto con PG³ y los átomos de oxígeno y carbono a los que están unidos un heterocicloalquilo C₃₋₆, opcionalmente sustituido; y LG representa un grupo de partida.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261720098P | 2012-10-30 | 2012-10-30 | |
| EP12306355.4A EP2727929A1 (en) | 2012-10-30 | 2012-10-30 | Method of preparation of alpha galactosyl ceramides compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR093270A1 true AR093270A1 (es) | 2015-05-27 |
Family
ID=47172560
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP130103950A AR093270A1 (es) | 2012-10-30 | 2013-10-30 | METODO DE PREPARACION DE COMPUESTOS DE a-GALACTOSILCERAMIDAS |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US10870671B2 (es) |
| EP (2) | EP2727929A1 (es) |
| JP (1) | JP6140830B2 (es) |
| CN (2) | CN104812769A (es) |
| AR (1) | AR093270A1 (es) |
| AU (1) | AU2013340901B2 (es) |
| BR (1) | BR112015009720B1 (es) |
| CA (1) | CA2888391C (es) |
| CU (1) | CU24311B1 (es) |
| CY (1) | CY1119697T1 (es) |
| DK (1) | DK2920194T3 (es) |
| ES (1) | ES2655655T3 (es) |
| HR (1) | HRP20171687T1 (es) |
| HU (1) | HUE035530T2 (es) |
| IL (1) | IL238515B (es) |
| LT (1) | LT2920194T (es) |
| MX (1) | MX363944B (es) |
| PL (1) | PL2920194T3 (es) |
| PT (1) | PT2920194T (es) |
| RU (1) | RU2662156C2 (es) |
| SI (1) | SI2920194T1 (es) |
| WO (1) | WO2014067995A1 (es) |
| ZA (1) | ZA201502844B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20210022051A (ko) * | 2018-06-15 | 2021-03-02 | 카보코드 에스.에이. | 당화된 스핑고이드 염기 및 그 제조 |
| CN110479184B (zh) * | 2019-08-05 | 2021-09-07 | 华侨大学 | 一种琼脂糖基乳化剂及其制备方法和应用 |
| WO2024050020A1 (en) * | 2022-08-31 | 2024-03-07 | Deciduous Therapeutics, Inc. | Invariant natural killer t-cell activators |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE758395A (fr) * | 1969-11-03 | 1971-05-03 | Upjohn Co | Procede de conversion d'halogenures de cis-glucosyle peracyles et nouveaux composes en derivant |
| US4310505A (en) * | 1979-11-08 | 1982-01-12 | California Institute Of Technology | Lipid vesicles bearing carbohydrate surfaces as lymphatic directed vehicles for therapeutic and diagnostic substances |
| FR2711138B1 (fr) * | 1993-10-12 | 1995-11-24 | Oreal | Céramides, leur procédé de préparation et leurs applications en cosmétique et en dermopharmacie. |
| CN1405172A (zh) | 2001-08-13 | 2003-03-26 | 青岛海洋大学 | 一种乳糖胺脂及其制备方法和应用 |
| CA2626997C (en) * | 2005-10-25 | 2014-12-23 | Ludwig Institute For Cancer Research | Analogs of alpha galactosylceramide and uses thereof |
| CA2661789C (en) | 2006-04-07 | 2014-06-03 | The Scripps Research Institute | Modified .alpha.-galactosyl ceramides for staining and stimulating natural killer t cells |
| CN101012254A (zh) | 2006-08-29 | 2007-08-08 | 中国海洋大学 | 一种α－半乳糖鞘糖脂的2’－OH衍生物及其制备方法 |
| CA2854725C (en) * | 2011-01-05 | 2019-10-22 | National Taiwan University | Methods for preparation of glycosphingolipids and uses thereof |
-
2012
- 2012-10-30 EP EP12306355.4A patent/EP2727929A1/en not_active Withdrawn
-
2013
- 2013-10-30 RU RU2015116422A patent/RU2662156C2/ru active
- 2013-10-30 PL PL13783936T patent/PL2920194T3/pl unknown
- 2013-10-30 DK DK13783936.1T patent/DK2920194T3/en active
- 2013-10-30 MX MX2015005592A patent/MX363944B/es active IP Right Grant
- 2013-10-30 CN CN201380056606.0A patent/CN104812769A/zh active Pending
- 2013-10-30 PT PT137839361T patent/PT2920194T/pt unknown
- 2013-10-30 CU CUP2015000042A patent/CU24311B1/es unknown
- 2013-10-30 HU HUE13783936A patent/HUE035530T2/en unknown
- 2013-10-30 CA CA2888391A patent/CA2888391C/en active Active
- 2013-10-30 CN CN201811555848.5A patent/CN109503682B/zh active Active
- 2013-10-30 AU AU2013340901A patent/AU2013340901B2/en active Active
- 2013-10-30 AR ARP130103950A patent/AR093270A1/es active IP Right Grant
- 2013-10-30 SI SI201330907T patent/SI2920194T1/en unknown
- 2013-10-30 BR BR112015009720-0A patent/BR112015009720B1/pt active IP Right Grant
- 2013-10-30 ES ES13783936.1T patent/ES2655655T3/es active Active
- 2013-10-30 US US14/439,642 patent/US10870671B2/en active Active
- 2013-10-30 LT LTEP13783936.1T patent/LT2920194T/lt unknown
- 2013-10-30 EP EP13783936.1A patent/EP2920194B1/en active Active
- 2013-10-30 WO PCT/EP2013/072711 patent/WO2014067995A1/en active Application Filing
- 2013-10-30 JP JP2015538504A patent/JP6140830B2/ja active Active
-
2015
- 2015-04-24 ZA ZA2015/02844A patent/ZA201502844B/en unknown
- 2015-04-28 IL IL238515A patent/IL238515B/en active IP Right Grant
-
2017
- 2017-11-06 HR HRP20171687TT patent/HRP20171687T1/hr unknown
- 2017-12-18 CY CY20171101324T patent/CY1119697T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR118341A2 (es) | Mezclas fungicidas ternarias | |
| CR20150663A (es) | Derivados de diazacarbazol como ligandos de tau para pet | |
| AR096684A1 (es) | Compuestos para tratar atrofia muscular espinal | |
| MD20180040A2 (ro) | Inhibitori ai virusului hepatic C | |
| PE20151606A1 (es) | DERIVADOS DE NAFTIRIDINA UTILES COMO ANTAGONISTAS DE LA AvB6 INTEGRINA | |
| AR102468A1 (es) | Métodos para la preparación de ribósidos | |
| CR20150418A (es) | Compuestos de tetrahidropirrolotiazina | |
| AR094712A1 (es) | Modificador de sabor dulce | |
| AR106141A1 (es) | Métodos e intermediarios para la preparación de derivados de ácidos biliares | |
| AR094812A1 (es) | Derivado de piridina monocíclico como inhibidor del fgfr | |
| RS54730B1 (sr) | Inhibitori beta sekretaze | |
| AR090928A1 (es) | Compuestos de hexahidropirano[3,4-d][1,3]tiazin-2-amina heterociclicos sustituidos | |
| RS54526B1 (en) | USE OF PIRAZOLOSPIROKETONE DERIVATIVES AS ACETYL-COA CARBOXYLASE INHIBITORS | |
| MA38583A1 (fr) | Dérivés de dolastatine 10 et d'auristatines | |
| ES2626801T3 (es) | Compuestos de triazolopiridina como inhibidores de pde10a | |
| EA201690911A1 (ru) | Соединения диметилбензойной кислоты | |
| IN2014MN01521A (es) | ||
| AR105494A1 (es) | Método para preparar derivados de ácido 3-(2-anilino-1-ciclohexil-1h-bencimidazol-5-il)propanoico sustituido | |
| AR092971A1 (es) | Inhibidores de agrecanasa | |
| AR090172A1 (es) | Proceso para la preparacion de carboxamidas | |
| AR089814A1 (es) | Compuestos que modulan la actividad de los proteasomas | |
| AR081893A1 (es) | Derivados de acido 1-(2-fluorobifenil-4-il)-alquil carboxilico para la terapia de la amiloidosis transtiretina | |
| AR090086A1 (es) | COMPUESTO DE 1H-INDAZOL-3-CARBOXAMIDA COMO INHIBIDORES DE LA GLUCOGENO SINTASA CINASA 3 b | |
| EA201491852A1 (ru) | Новые пиразольные соединения | |
| MY185971A (en) | Pyranodipyridine compound |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |